About Lorence Kim
Form D filings for Odyssey Therapeutics from 2023 to 2024 list Lorence Kim as director.
Form D filings also name Lorence Kim as a director at Abata Therapeutics.
Lorence Kim first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Lorence Kim in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Lorence Kim works with at each company, as listed on that company's latest Form D.
Odyssey Therapeutics, Inc. · Form D/A, Aug 14, 2024
TW
Timothy Walbert
Director
Charles Baum
Director
GG
Gary Glick
President & CEO, director
JC
Jill Carroll
Director
JL
Jeffrey Leiden
Director
IS
Ian Smith
Director
VO
Valerie Odegard
Director
CG
Carl Gordon
Director
Abata Therapeutics, Inc. · Form D, Dec 27, 2023
SS
Samantha Singer
Chief Executive Officer and director
LD
Leonard Dragone
Executive officer
VO
Valerie Odegard
Director
SS
Stephen Sofen
Executive officer
SL
Sandy Lazzari
Executive officer
SC
Shelley Chu
Director
NM
Nagesh Mahanthappa
Director
JT
John Trzupek
Executive officer
AC
Abbie Celniker
Director
MF
Mitch Finer
Director
DK
David Kaufman
Director
EM
Ellen Cahir-Mcfarland
Executive officer